NCT02216292

Brief Summary

Human milk is the best source of enteral nutrition for the preterm infant. However during the infants first hours and days of life breastmilk from the own mother is usually not available. Until May 2012 the practice in the Neonatal Division of the Department of Pediatrics /Medical University Vienna was to start with formula feedings within the first 6 hours of life of a premature infant and switch over to breastmilk as soon it was available. In June 2012 the investigators changed this feeding regimen and started to use single donor milk of mothers of preterm infants for the first hours and days of the preterm infants life. In a prospective observational study the investigators evaluated the impact of single donor milk from preterm infants on time to full enteral feedings, gastrointestinal tolerance and NEC incidence in preterm infants with a birthweight below 1500 grams and a gestational below 32 weeks. Data will be compared with a historical control group starting with preterm formula as source of enteral nutrition. The investigators hypothesize that starting enteral nutrition with single donor milk of mothers from preterm infants with shorten time to full enteral feedings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2012

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 11, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 13, 2014

Completed
Last Updated

August 13, 2014

Status Verified

August 1, 2014

Enrollment Period

10 months

First QC Date

August 11, 2014

Last Update Submit

August 11, 2014

Conditions

Keywords

preterm single donor milkhuman milkvery lo birth weight infantsenteral feedingsNEC

Outcome Measures

Primary Outcomes (1)

  • Time to full enteral feeding

    Full enteral feedings are defined as an enteral inane of 135-145ml/kg/d

    birth up to 40 weeks of gestation

Secondary Outcomes (4)

  • necrotizing enterocolitis

    birth to 40 weeks of gestation

  • Gastric residuals

    birth to 7th day of life

  • Frequency of stool

    birth until 14th day of life

  • culture positive sepsis

    birth to 40th week of gestation

Other Outcomes (1)

  • body weight

    birth to 40th week of gestation

Study Arms (2)

Preterm Single Donor Milk Group

The prospective study group = preterm single donor milk group (PSDM-Group) from June 2012 - April 2013

Other: Preterm Single Donor Milk Group

Control Group

Retrospective control group receiving no donor milk = control group from March 2011 - May 2012

Other: Control Group

Interventions

Infants received preterm formula during their first days of life until breastmilk from their own mother was available

Control Group

Infants received preterm single donor milk during their first days of life until breastmilk from their own mother was available

Preterm Single Donor Milk Group

Eligibility Criteria

Age1 Minute - 1 Year
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

inborn very low birth weight infants with a birthweight \<1500g and a gestational age \<32 weeks

You may qualify if:

  • very low birth weight infants with a birthweight \<1500g
  • Gestational Age \<32 weeks
  • Informed consent

You may not qualify if:

  • major congenital malformations
  • systemic metabolic diseases
  • short bowl syndrome
  • gastrointestinal abnormalities
  • when preterm infant was transferred or discharged

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Vienna

Vienna, Austria

Location

MeSH Terms

Conditions

Infant, Premature, Diseases

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Infant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Nadja Haiden, Prof.MD

    Medical University of Vienna, Department of Pediatrics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Assoc. Prof.

Study Record Dates

First Submitted

August 11, 2014

First Posted

August 13, 2014

Study Start

June 1, 2012

Primary Completion

April 1, 2013

Study Completion

June 1, 2014

Last Updated

August 13, 2014

Record last verified: 2014-08

Locations